Literature DB >> 10421622

Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro.

H Gutmann1, M Török, G Fricker, J Huwyler, C Beglinger, J Drewe.   

Abstract

Multidrug resistance-associated protein (MRP) is a transport system that is involved in the elimination of xenobiotics and biologically active endogenous substrates. Recently, the presence of MRP has been demonstrated in cultured brain capillary endothelial cells (BCECs). The time-dependent, functional expression of MRP in porcine BCECs was investigated to assess the value of this cell culture model for drug transport at the blood-brain barrier. Western blot analysis was used to investigate MRP expression in freshly isolated porcine BCECs and compared to MRP expression at days 8 and 10 in culture. Subcellular localization of MRP was investigated by immunocytochemistry with an MRP-specific monoclonal antibody, MRPr1. Functional activity of MRP was assessed by efflux studies with the fluorescent MRP substrate glutathione-methylfluorescein (GS-MF). No significant MRP expression was detected in freshly isolated endothelial cells. However, MRP expression is up-regulated in cell culture in a time-dependent manner. Immunostaining revealed predominantly perinuclear and, to a lesser degree, plasma membrane localization of MRP. At 10 degrees C GS-MF efflux was significantly decreased, indicating the involvement of an energy-dependent transport system. Efflux of GS-MF was apparently inhibited by MK571, a specific inhibitor for MRP. Porcine BCECs demonstrate up-regulation of functional MRP expression during culture, as observed in human tissue, and therefore might serve as a useful in vitro system for studying MRP-mediated blood-brain barrier transport.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421622

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  16 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

Review 3.  Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  NeuroRx       Date:  2005-01

4.  Effect of probenecid on fluorescein transport in the central nervous system using in vitro and in vivo models.

Authors:  H Sun; D W Miller; W F Elmquist
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

5.  Ivermectin excretion by isolated functionally intact brain endothelial capillaries.

Authors:  S Nobmann; B Bauer; G Fricker
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

6.  Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo.

Authors:  Stephan Fellner; Björn Bauer; David S Miller; Martina Schaffrik; Martina Fankhänel; Thilo Spruss; Günther Bernhardt; Claudia Graeff; Lothar Färber; Harald Gschaidmeier; Armin Buschauer; Gert Fricker
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

7.  The blood-brain barrier studied in vitro across species.

Authors:  Maj Schneider Thomsen; Nanna Humle; Eva Hede; Torben Moos; Annette Burkhart; Louiza Bohn Thomsen
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.240

8.  Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells.

Authors:  Simone S E Nielsen; Piotr Siupka; Ana Georgian; Jane E Preston; Andrea E Tóth; Siti R Yusof; N Joan Abbott; Morten S Nielsen
Journal:  J Vis Exp       Date:  2017-09-24       Impact factor: 1.355

Review 9.  Advancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.

Authors:  Li Xing; Yiding Hu; Yurong Lai
Journal:  AAPS J       Date:  2009-06-03       Impact factor: 4.009

Review 10.  Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.

Authors:  Sumio Ohtsuki; Tetsuya Terasaki
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.